Joining the WHO Programme for International Drug Monitoring

Overview

The WHO Programme for International Drug Monitoring provides a forum for WHO member states to collaborate in pharmacovigilance. The administration of the WHO Programme is shared. In accordance with an agreement between WHO and the Government of Sweden, WHO Headquarters, Geneva, is responsible for policy issues while the operational responsibility rests with the Uppsala Monitoring Centre.